Author

W.-L. Ma

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

H.-C. Wang· 1 shared J.-C. Yang· 1 shared L. Chen· 1 shared W.-C. Chang· 1 shared W.-C. Cheng· 1 shared W.-M. Chung· 1 shared Y.-C. Hung· 1 shared Y.-P. Ho· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

H.-C. Wang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Low-Density Lipoprotein Receptor-Mediated Lipidome-Transcriptome Reprogramming Impulses to Cisplatin Insensitivity

W.-C. Chang, H.-C. Wang, W.-C. Cheng, J.-C. Yang, W.-M. Chung, L. Chen, Y.-P. Ho, Y.-C. Hung, W.-L. Ma

This study identifies LDLR-mediated lipidome-transcriptome reprogramming as a mechanism for cisplatin insensitivity in ovarian cancer and demonstrates a lipid-based drug delivery strategy to enhance chemotherapy efficacy.

bioRxiv · Dec 21, 2018 · PreprintCancer Biology